We have previously described the case of a patient with Wilson’s disease who developed copper deficiency myeloneuropathy (CDM) 11 . da Silva-Júnior FP, Machado AA, Lucato LT, Cançado EL, Barbosa ER. Copper deficiency myeloneuropathy in a patient with Wilson disease. Neurology 2011;76:1673-1674. , 22 . da Silva-Júnior FP, Lucato LT, Machado AA, Barbosa ER. Copper deficiency in Wilson’s disease: an avoidable complication of treatment. Mov Disord 2011;26:2448-2449. . One year after zinc withdrawal, mild improvement of sensory symptoms was reported, with unchanged neurologic examination. Urinary copper excretion has increased from 7.4 to 80μg/24 hours and serum zinc level has decreased from 311 to 106μg/dL. Resolution of MRI findings was observed ( Figure ). She remains on regular clinical monitoring. These results indicate that zinc withdrawal, without copper supplementation, was enough to prevent CDM progression in our patient. Early diagnosis and management of CDM probably have accounted for this satisfactory outcome.
. Initial sagittal (A); axial (B); T2--weighted images of the cervical spine demonstrate bilateral and symmetric hyperintense lesions involving the dorsal columns of the cervical spinal cord, extending from C1 to C6 (arrows); one-year follow-up exam discloses resolution of the lesions in the sagittal (C); axial (D); T2-weighted images.
References
-
1da Silva-Júnior FP, Machado AA, Lucato LT, Cançado EL, Barbosa ER. Copper deficiency myeloneuropathy in a patient with Wilson disease. Neurology 2011;76:1673-1674.
-
2da Silva-Júnior FP, Lucato LT, Machado AA, Barbosa ER. Copper deficiency in Wilson’s disease: an avoidable complication of treatment. Mov Disord 2011;26:2448-2449.
Publication Dates
-
Publication in this collection
Mar 2014
History
-
Received
15 Oct 2013 -
Accepted
22 Oct 2013